Yanagisawa, Takafumi
Mori, Keiichiro
Kawada, Tatsushi
Katayama, Satoshi
Tsujino, Takuya
Maenosono, Ryoichi
Toyoda, Shingo
Nukaya, Takuhisa
Morinaka, Hirofumi
Tamura, Keita
Fukuokaya, Wataru
Urabe, Fumihiko
Murakami, Masaya
Bekku, Kensuke
Takahara, Kiyoshi
Fujita, Kazutoshi
Azuma, Haruhito
Araki, Motoo
Inamoto, Teruo
Komura, Kazumasa
Kimura, Takahiro
,
Article History
Received: 4 August 2025
Accepted: 24 December 2025
First Online: 25 February 2026
Declarations
:
: Takahiro Kimura has received consulting or advisory fees from Astellas, Bayer, Janssen, Sanofi, and Takeda. The other authors declare no conflicts of interest related to this manuscript.
: This study was approved by the Institutional Review Board of the principal institution, Osaka Medical and Pharmaceutical University (approval number: RIN–750–2571).
: Informed consent was waived due to retrospective nature.
: Informed consent was waived due to retrospective nature.